Search research articles
Contact Us
Filters
Showing results (161-170 of 164) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 164 results.
Pharmacology & Therapeutics
|
August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeutic
Paul Dent, Adly Yacoub, Hossein A Hamed, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2023
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis
Santanu Maji, Anjan K Pradhan, Amit Kumar, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules
Michael Hedvat, Luni Emdad, Swadesh K Das, et al.
International Journal of Oncology
|
October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)
Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 164) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 164 results.
Pharmacology & Therapeutics
|
August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeutic
Paul Dent, Adly Yacoub, Hossein A Hamed, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2023
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis
Santanu Maji, Anjan K Pradhan, Amit Kumar, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules
Michael Hedvat, Luni Emdad, Swadesh K Das, et al.
International Journal of Oncology
|
October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)
Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Page
of 17